Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 4 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 8Sarcoma 7Osteosarcoma 4Lymphoma 4Wilms Tumor 3Neuroectodermal Tumors, Primitive, Peripheral 3Neuroblastoma 3Neoplasms 3Carcinoma, Renal Cell 3Unspecified Adult Solid Tumor, Protocol Specific 2Retinoblastoma 2Optic Nerve Glioma 2Melanoma 2Medulloblastoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Hodgkin Disease 2Carcinoma, Hepatocellular 2Astrocytoma 2Waldenstrom Macroglobulinemia 1Uveal Melanoma 1Thrombocytopenia 1Testicular Neoplasms 1Stomach Neoplasms 1Solid Tumors 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma, Alveolar Soft Part 1Rhabdomyosarcoma 1Rhabdoid Tumor 1

Interventions

Bortezomib 9Cyclophosphamide 7tanespimycin 4fludarabine phosphate 4Vorinostat 4Paclitaxel 4Filgrastim 4Carboplatin 4fludarabine 3Peripheral Blood Stem Cell Transplantation 3Lenalidomide 3Irinotecan 3Everolimus 3Etoposide 3Doxorubicin 3Dasatinib 3Azacitidine 3sargramostim 2romidepsin 2laromustine 2ixabepilone 2entinostat 2belinostat 2Whole-Body Irradiation 2Vincristine 2Topotecan 2Tacrolimus 2Radiotherapy 2Prednisone 2Pharmacogenomic Testing 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Immunoblastic Lymphadenopathy × Ifosfamide × Clear all
NCT01590732 2018-09-19

Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma

M.D. Anderson Cancer Center

Phase 1 Completed
22 enrolled
Lymphoid

Immunoblastic Lymphadenopathy, Mycosis Fungoides, Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic, Enteropathy-Associated T-Cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡